A method for treating a tumor, comprising identifying a tumor as a glioblastoma tumor and implanting in the tumor identified as a glioblastoma tumor, as least one diffusing alpha-emitter radiation therapy (DaRT) source with a suitable radon release rate and for a given duration, such that the source provides during the given duration a cumulated activity of released radon between 3.7 Mega becquerel (MBq) hour and 8.8 MBq hour, per centimeter length.

A method for treating a cancerous tumor, by implanting in the cancerous tumor as least one diffusing alpha-emitter radiation therapy (DaRT) source with a suitable radon release rate and for a given duration, such that the source provides during the given duration a cumulated activity of released radon of at least 10 Mega becquerel (MBq) hour, per centimeter length. Optionally, the sources are implanted in an array of sources, each source separated from its neighboring sources in the array by not more than 4.5 millimeters.

A method for treating a tumor, comprising identifying a tumor as a breast cancer or prostate cancer tumor and implanting in the tumor identified as a breast cancer or prostate cancer tumor, as least one diffusing alpha-emitter radiation therapy (DaRT) source with a suitable radon release rate and for a given duration, such that the source provides during the given duration a cumulated activity of released radon between 3.5 Mega becquerel (MBq) hour and 8 MBq hour, per centimeter length.

A method for treating a tumor, comprising identifying a tumor as a melanoma tumor and implanting in the tumor identified as a melanoma tumor, as least one diffusing alpha-emitter radiation therapy (DaRT) source with a suitable radon release rate and for a given duration, such that the source provides during the given duration a cumulated activity of released radon between 3.4 Mega becquerel (MBq) hour and 8.6 MBq hour, per centimeter length.

The present disclosure may provide a system for radiotherapy planning. The system may obtain planning information relating to at least one beam to be delivered to a subject in a treatment of the subject. The system may also generate an input of a fluence map generation model based on the planning information. For each of the at least one beam, the system may further generate at least one deliverable fluence map relating to at least one segment of the beam based on the input and the fluence map generation model.

Systems, kits and methods for preparing an injection system and/or treating target lesions with a selective internal radiation therapy which includes a double-barrel syringe loaded with a two-component tissue glue and radioisotope loaded microspheres. The microspheres are loaded into the syringe based on the size of the target location and are administered with a needle or dual-lumen catheter. Dosing regimens for treating breast cancer lesions or surgical beds up to 130 mm in diameter and hepatocellular carcinoma lesions up to 50 mm are included.

Systems and methods for generating a radiotherapy treatment plan using information about gantry angle-indexed dose (GAID) variation are discussed. An exemplary system can include an interface to receive a beam model for use in the radiation machine, and a processor that can determine, for the radiation machine, a GAID variation represented by a plurality of radiation doses at different gantry angles. The processor can determine a radiation treatment plan for the patient using the beam model and the GAID variation.

A correlation between a CT value and a water equivalent thickness ratio distribution for each patient can be corrected without increasing a treatment time, and more accurate treatment can be realized. A treatment planning system 112 which generates a treatment plan for irradiating an irradiation target with a particle beam calculates a correction amount of a water equivalent thickness ratio of a first treatment plan created in advance, calculates a water equivalent thickness ratio distribution based on the correction amount and the first treatment plan, and creates a second treatment plan from the water equivalent thickness distribution.

The disclosure provides systems and methods for adjusting a multi-leaf collimator (MLC). The MLC includes a plurality of cross-layer leaf pairs, each cross-layer leaf pair of the plurality of cross-layer leaf pairs includes a first leaf located in a first layer of leaves and a second leaf opposingly located in a second layer of leaves. For at least one cross-layer leaf pair, an effective cross-layer leaf gap to be formed between the first leaf and the second leaf may be determined; at least one of the first leaf or the second leaf may be caused to move to form the effective cross-layer leaf gap; and an in-layer leaf gap may be caused, based on the effective cross-layer leaf gap, to be formed between the first leaf and an opposing first leaf in the first layer. A size of the in-layer leaf gap may be no less than a threshold.

A dosimetric evaluation tool and method is used to determine how well the prescription isodose volume (PIV) conform to the size and shape both the tumor volume (TV) and the healthy tissue in radiotherapy treatment plans. The innovative, ideal, and universal dosimetric evaluation tools are Conformity Index (CI) and Unconformity Indexes (UCI.sub.underdose and UCI.sub.overdose). CI measures the conformity of the radiotherapy planning, and UCI.sub.underdose and UCI.sub.overdose measure the unconformity of the radiotherapy planning. In other words, UCI.sub.underdose and UCI.sub.overdose reflect the negative effect of dose distribution in planning, and CI reflects the positive effect of dose distribution.